Murphy Analytics Announces Update of Coverage on Axxess Pharma Inc.
07 Maggio 2014 - 1:30PM
Marketwired
Murphy Analytics Announces Update of Coverage on Axxess Pharma Inc.
ST. LOUIS, MO--(Marketwired - May 7, 2014) - Murphy Analytics
(MA) has updated coverage on Axxess Pharma Inc. (PINKSHEETS:
AXXE). The Update Report contains a detailed discussion of
AXXE's planned business operations, market dynamics, financials,
potential cash flows, and risks. The Update Report is
available at:
http://www.murphyanalytics.com/uploads/AXXE_Update.pdf.
Analyst Patrick Murphy notes in the report: "A review of
AXXE press releases over the preceding quarters sheds light on the
Company's optimism as AXXE has made a significant number of
improvements and expansions of its distribution channels, product
lineup, marketing efforts, and corporate operations. The
Company's 5/1/14 announcement that TapouT will be available in over
160 U.S. military stores reflects both the substantial progress
AXXE has made as well as the opportunity before the
company."
About Murphy Analytics Murphy Analytics is an independent
investment research firm providing coverage of microcap
stocks. Utilizing institutional caliber, fundamental analysis,
Murphy Analytics helps readers become more informed about equities
without extensive analyst coverage. Murphy Analytics LLC is
owned by Patrick J. Murphy, who has nearly 20 years of capital
markets experience, providing institutional investment and
transaction analysis across a range of asset classes including
microcap equities, commercial real estate debt and equity,
municipal derivatives and public finance, venture capital, fixed
income, CMBS and mortgage REIT's.
Disclosure: MA was paid $5,000 by the Company in advance of
the publication of an Initiation Report dated 11/5/13 and $2,500 in
advance of the publication of this report. Neither MA nor the
analyst owns or trades the shares of covered
companies. Statements herein may contain forward-looking
statements and are subject to significant risks and uncertainties
affecting results. MA provides no assurance as to the subject
company's plans or ability to effect proposed actions and cannot
project capabilities, intent, resources, experience, or
results. This report is neither a solicitation to buy nor an
offer to sell securities and is to be used for informational
purposes only and should not be used as basis for investment
decisions. MA is not an investment advisor or broker/dealer and
this report does not provide investment advice.
Contact: Patrick J. Murphy, CFA Email Contact
Grafico Azioni Allstar Health Brands (PK) (USOTC:ALST)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Allstar Health Brands (PK) (USOTC:ALST)
Storico
Da Dic 2023 a Dic 2024
Notizie in Tempo Reale relative a Allstar Health Brands Inc (PK) (OTCMarkets): 0 articoli recenti
Più Axxess Pharma, Inc. (PC) Articoli Notizie